Health-Related Quality of Life and Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy

Current Problems in Cancer

Volumn 33, Issue 3, 2009, Pages 203-218

  McQuellon, Richard ^a   Duckworth, Katie E ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; CYTOREDUCTIVE SURGERY; EMOTION; FAMILY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LEISURE; PERITONEUM CANCER; QUALITY OF LIFE; RELIGION; SEXUALITY; SURGICAL TECHNIQUE; WORK;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HEALTH STATUS; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS; QUALITY OF LIFE;

EID: 67651252898     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2009.06.008     Document Type: Article

References (34)

1. Sugarbaker P.H., Barofsky I., Rosenberg S.A., and Gianola F.J. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 91 (1982) 17-23
2. Blazeby J.M., Avery K., Sprangers M., Pikhart H., Fayers P., and Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 24 (2006) 3178-3186
3. McQuellon R., Gavazzi C., Piso P., Swain D., and Levine E. Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): Recommendations for care. J Surg Oncol 98 (2008) 300-305
4. McQuellon R.P., Loggie B.W., Fleming R.A., Russell G.B., Lehman A.B., and Rambo T.D. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27 (2001) 65-73
5. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
6. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
7. Ferrell B.R., Dow K.H., and Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res 4 (1995) 523-531
8. Grant M., Ferrell B., Schmidt G.M., Fonbuena P., Niland J.C., and Forman S.J. Measurement of quality of life in bone marrow transplantation survivors. Qual Life Res 1 (1992) 375-384
9. Cella D.F., and Tulsky D.S. Measuring quality of life today: Methodological aspects. Oncology 4 (1990) 29-38
10. Cella D.F., and Tulsky D.S. Quality of life in cancer: Definition, purpose, and method of measurement. Cancer Invest 11 (1993) 327-336
11. Cella D.F. Methods and problems in measuring quality of life. Support Care Cancer 3 (1995) 11-22
12. Cella D.F. Quality of life outcomes: Measurement and validation. Oncology 10 suppl (1996) 233-246
13. Cella D.F., and Bonomi A.E. Measuring quality of life: 1995 Update. Oncology 9 suppl (1995) 47-60
14. McQuellon R.P., Thaler H.T., Cella D., and Moore D.H. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol 101 (2006) 296-304
15. Moore D.H., Blessing J.A., McQuellon R.P., Thaler H.T., Cella D., Benda J., et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 22 (2004) 3113-3119
16. Verwaal V.J., van Ruth S., de Bree E., van Slooten G.W., van Tinteren H., Boot H., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative Surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
17. Loggie B.W., Fleming R.A., McQuellon R.P., Russell G.B., and Geisinger K.R. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66 (2000) 561-568
18. McQuellon R.P., Loggie B.W., Lehman A.B., Russell G.B., Fleming R.A., Shen P., et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10 (2003) 155-162
19. McQuellon R.P., Danhauer S.C., Russell G.B., Shen P., Fenstermaker J., Stewart J.H., et al. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 14 (2007) 1105-1113
20. McQuellon R.P., Russell G.B., Shen P., Stewart J.H., Saunders W., and Levine E.A. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol 15 (2008) 125-133
21. McQuellon R., Russell G., Campbell C., Duckworth K., Beard R., Shen P., et al. Assessing depressive symptoms with the Center for Epidemiologic Studies Depression-Scale prior to cytoreductive surgery + intraperitoneal hyperthermic chemotherapy. Psycho-Oncology 18 S1-S96 (2009) S42
22. Alexander R., Mavroukakis S., Libutti S., Pingpank J., Beresneva T., Marden S., et al. Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM). Ann Surg Oncol 11 (2004) S109
23. Schmidt U., Dahlke M.H., Klempnauer J., Schlitt H.J., and Piso P. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31 (2005) 53-58
24. Jess P., Iversen L.H., Nielsen M.B., Hansen F., Laurberg S., and Rasmussen P.C. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: A prospective study. Dis Colon Rectum 51 (2008) 868-874
25. Tuttle T.M., Zhang Y., Greeno E., and Knutsen A. Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 13 (2006) 1627-1632
26. Andrykowski M.A., Brady M.J., Greiner C.B., Altmaier E.M., Burish T.G., Antin J.H., et al. "Returning to normal" following bone marrow transplantation: Outcomes, expectations and informed consent. Bone Marrow Transplant 15 (1995) 573-581
27. Horning S.J. Follow-up of adult cancer survivors: New paradigms for survivorship care planning. Hematol Oncol Clin North Am 22 (2008) 201-210
28. McQuellon R.P., and Cowan M.A. Turning toward death together: Conversation in mortal time. Am J Hosp Palliat Care 17 (2000) 312-318
29. Cella D., Hahn E.A., and Dineen K. Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Qual Life Res 11 (2002) 207-221
30. Engel G.L. The need for a new medical model: A challenge for biomedicine. Science 196 (1977) 129-136
31. Wilson I.B., and Cleary P.D. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. J Am Med Assoc 273 (1995) 59-65
32. Velikova G., Brown J.M., Smith A.B., and Selby P.J. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 86 (2002) 51-59
33. Velikova G., Booth L., Smith A.B., Brown P.M., Lynch P., Brown J.M., et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. J Clin Oncol 22 (2004) 714-724
34. Velikova G., Awad N., Coles-Gale R., Wright E.P., Brown J.M., and Selby P.J. The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology 17 (2008) 690-698